Tag: Novartis
Pfizer is again the number one in the pharmaceutical industry
vaccine production Comirnaty alone delivered $36.8 billion last year, the highest annual sales for any single pharmaceutical product. (Photo: AP) Frankfort, New York After a one-year hiatus, the US pharmaceutical…
Pfizer is again the number one in the pharmaceutical industry
vaccine production Comirnaty alone delivered $36.8 billion last year, the highest annual sales for any single pharmaceutical product. (Photo: AP) Frankfort, New York After a one-year hiatus, the US pharmaceutical…
How companies cheat on climate promises
Munich Carsten Warnecke and his colleagues from the non-profit NewClimate Institute climate strategies wanted to present “ambitious companies” to encourage imitation. But what the climate experts found in their analysis…
Novartis triples profit thanks to Roche stake sale
Novartis logo The pharmaceutical company not only increased its profits significantly through the sale of Roche shares in 2021. (Photo: Reuters) Zurich The Swiss pharmaceutical company Novartis made a profit…
Reliable dividends & consistently high profits
dividend yield Dividends are far more stable than corporate earnings and stock prices. (Photo: Stephan Schmitz) Dusseldorf The idea sounds great: buy stocks with high dividends and low prices. This…
Reliable dividends & consistently high profits
dividend yield Dividends are far more stable than corporate earnings and stock prices. (Photo: Stephan Schmitz) Dusseldorf The idea sounds great: buy stocks with high dividends and low prices. This…
Curevac share: head of technology leaves biotech company
Mariola Fotin-Mleczek Curevac’s Chief Technology Officer will leave the company at the end of January. (Photo: CureVac) Frankfurt At the Tübingen Curevac, the upheaval continues with another prominent departure from…
Corden Pharma: vaccine supplier is for sale
Moderna vaccine Corden Pharma manufactures lipids needed for the vaccine. (Photo: imago images/ZUMA Wire) Frankfurt According to financial sources, the German pharmaceutical supplier Corden Pharma is for sale. Owner International…
AI expert Lauterbach is to advise payment service providers
Anastassia Lauterbach The AI expert is considered a gifted networker. (Photo: Marc-Steffen Unger for Handelsblatt) new York The former Wirecard controller Anastassia Lauterbach will be European head of the New…
Corona drug from Novartis: Positive study results
Research at Novartis The pharmaceutical giant has high hopes for its new Covid drug. (Photo: AP) Frankfurt. The Covid-19 drug candidate from Novartis and the Swiss biotech company Molecular Partners…
In the fight against cancer
Frankfurt The fight against the coronavirus has been in the headlines for two years, but there has also been immense progress in the fight against cancer. Because in the long…
In the fight against cancer
Frankfurt The fight against the coronavirus has been in the headlines for two years, but there has also been immense progress in the fight against cancer. Because in the long…
Investors can still find bargains here
Novartis, Exxon, Philipp Morris, Samsung Relatively inexpensive stocks with potential returns. (Photo: Novartis, Visa, Imago, Bloomberg) Dusseldorf More than ten years of boom and a doubling of global prices since…
Investors can still find bargains here
Novartis, Exxon, Philipp Morris, Samsung Relatively inexpensive stocks with potential returns. (Photo: Novartis, Visa, Imago, Bloomberg) Dusseldorf More than ten years of boom and a doubling of global prices since…
Pharmaceutical industry is realigning itself
Rather, the change is marked by larger spin-offs – and the strategy of the big pharmaceutical companies to concentrate more on the innovative pharmaceutical business. According to experts, these plans…
Pharmaceutical industry is realigning itself
Rather, the change is marked by larger spin-offs – and the strategy of the big pharmaceutical companies to concentrate more on the innovative pharmaceutical business. According to experts, these plans…
Investors can still find bargains here
Novartis, Exxon, Philipp Morris, Samsung Relatively cheap stocks with potential returns. (Photo: Novartis, Visa, Imago, Bloomberg) Dusseldorf More than ten years of boom and a doubling of global prices since…
Investors can still find bargains here
Novartis, Exxon, Philipp Morris, Samsung Relatively cheap stocks with potential returns. (Photo: Novartis, Visa, Imago, Bloomberg) Dusseldorf More than ten years of boom and a doubling of global prices since…
Apple rises above three trillion – Handelsblatt Morning Briefing
Good morning dear readers, On Monday evening, the stock exchange world celebrated another record: For the first time in history, a corporation reached a market value of three trillion dollars.…
Investors can still find bargains here
Novartis, Exxon, Philipp Morris, Samsung Relatively cheap stocks with potential returns. (Photo: Novartis, Visa, Imago, Bloomberg) Dusseldorf More than ten years of boom and a doubling of global prices since…